Login to Your Account

Novartis backs Seventure’s €160M venture fund targeting gut microbiome

By Cormac Sheridan
Staff Writer

Monday, December 14, 2015

DUBLIN – Seventure Partners has added Novartis AG as an investor in a new closing of its Health for Life Capital fund, taking the total to €160 million (US$175 million).

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription